1 completed, 1 unknown, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow bisantrene: new trials by email Literature Review of bisantrene trials Research Report on bisantrene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS Bisantrene Dihydrochloride (high dose), Bisantrene Dihydrochloride (low dose), Cytarabine Hydrochloride - Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 1 | Withdrawn | Racura Oncology Ltd | 2022-07-29 | 2023-10-03 | |
| Bisantrene Combination for Resistant AML Bisantrene, Fludarabine, Clofarabine - Myelogenous Leukemia, Acute | Phase 2 | Unknown | Sheba Medical Center | 29 | 2021-08-02 | 2023-11-28 |
| Bisantrene for Relapsed /Refractory AML Bisantrene - Acute Myelogenous Leukemia, Allogeneic Stem Cell Transplantation | Phase 2 | Completed | Sheba Medical Center | 10 | 2019-07-18 | 2020-08-07 |
Leukemia, Myeloid, Acute (3) · Leukemia, Myelomonocytic, Chronic (1)
Sheba Medical Center (2) · Racura Oncology Ltd (1)
Israel (2) · Australia (1)
Arnon Nagler, MD (1) · Marinella Messina, PhD (1)